Home NDC 72205-051 Albendazole
Product NDC 72205-051
11-digit product format 722050051
Labeler code 72205
Product ID 72205-051_594f7aab-b336-4d6d-b702-a33346c69645
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Albendazole
Dosage form TABLET
Route ORAL
Labeler Novadoz Pharmaceuticals LLC
Application ANDA213435
Marketing category ANDA
Marketing start 2021-02-24
Substance ALBENDAZOLE
Active strength 200 mg/1
Pharmacologic classes Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213435-001 ALBENDAZOLE ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A213435-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 4b0b4de00fa7…2022-03-09 01:35 UTC 2022-03 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 5aa47cf7b7d7…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213435-001 ALBENDAZOLE 200MG TABLET / ORAL AB 2021-01-21 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base Albendazole
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ALBENDAZOLE 200 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination F4216019LN Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 199672 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 72205-051-08 Albendazole 2 in 1 BOTTLE TABLET 2 1 72205-051-28 Albendazole 28 in 1 BOTTLE TABLET 28 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 72205-051 ALBENDAZOLE TABLET [NOVADOZ PHARMACEUTICALS LLC] 1 Current NDC, Legacy NDC, 2 package rows 20210226_594f7aab-b336-4d6d-b702-a33346c69645.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 72205-051-08 72205005108 2 TABLET in 1 BOTTLE (72205-051-08) 2 tablet 2021-02-24 0000-00-00 No No Current 72205-051-28 72205005128 28 TABLET in 1 BOTTLE (72205-051-28) 28 tablet 2021-02-24 0000-00-00 No No Current